Comments
Loading...

Cytokinetics

CYTKNASDAQ
Logo brought to you by Benzinga Data
$49.97
At close: Jan 30, 4:00 PM EDT
$49.97
0.000.00%
After Hours: 4:00 PM EDT

Cytokinetics (NASDAQ:CYTK) Stock Quotes, Forecast and News Summary

Cytokinetics Stock (NASDAQ: CYTK) stock price, news, charts, stock research, profile.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
4
Oct 24
7
Nov 24
6
Dec 24
5
Jan
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
Open-
Close-
Volume / Avg.0 / 1.24M
Day Range- - -
52 Wk Range44.49 - 84.05
Market Cap$5.90B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
61
Short Interest-
Days to Cover12.3

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
CYTK

FAQ

Q

How do I buy Cytokinetics (CYTK) stock?

A

You can purchase shares of Cytokinetics (NASDAQ:CYTK) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Cytokinetics (CYTK) competitors?

A

There are no as such competitors for Cytokinetics.

Q

What is the forecast, or price target, for Cytokinetics (CYTK) stock?

A

Cytokinetics has a consensus price target of $80.16.

Q

What is the current price for Cytokinetics (CYTK)?

A

The stock price for Cytokinetics (NASDAQ: CYTK) is $49.97 last updated January 30, 2025 at 4:00 PM EST.

Q

Does Cytokinetics (CYTK) pay a dividend?

A

There are no upcoming dividends for Cytokinetics.

Q

When is Cytokinetics (NASDAQ:CYTK) reporting earnings?

A

Cytokinetics’s Q4 earnings are confirmed for Tuesday, February 25, 2025.

Q

Is Cytokinetics (CYTK) going to split?

A

There is no upcoming split for Cytokinetics.

Q

What sector and industry does Cytokinetics (CYTK) operate in?

A

Cytokinetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.